Avapritinib - Blueprint Medicines
At a glance
- Drug Originator Blueprint Medicines
- Drug Licenced by CStone Pharmaceuticals; Jiangsu Hengrui Medicine Co.; Neopharm Ltd
- Drug Class 2 ring heterocyclic compounds; Amines; Antineoplastics; Pyrazoles; Pyrimidines; Pyrroles; Skin disorder therapies; Small molecules; Triazines
- Mechanism of Action Platelet-derived growth factor alpha receptor antagonists; Proto-oncogene protein c-kit inhibitors
- USA Patent Applicants BLUEPRINT MEDICINES
- USA Patents 8
- NDAs 1
- International Patents 70
- Patent Applications 33
Table of Contents
Disclaimer